Transition Therapeutics Announces Results of Phase 1 Clinical Study of TT-401
18. Juni 2012 07:01 ET
|
Transition Therapeutics Inc.
TORONTO, June 18, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) announced the results of a single ascending dose escalation study of...
Transition Therapeutics Announces ELND005 Presentations at the 12th International Stockholm/Springfield Symposium on Advances in Alzheimer Therapies
14. Mai 2012 07:01 ET
|
Transition Therapeutics Inc.
TORONTO, May 14, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that a mini-symposium entitled "The Emerging Clinical...
Transition Therapeutics Announces Third Quarter Fiscal 2012 Financial Results
08. Mai 2012 16:01 ET
|
Transition Therapeutics Inc.
TORONTO, May 8, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2012 Financial Results on Tuesday, May 8th, at 4:30 P.M. EDT
04. Mai 2012 14:45 ET
|
Transition Therapeutics Inc.
TORONTO, May 4, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, May 8, 2012 at 4:30 P.M. EDT to...
Transition Therapeutics Announces ELND-005 Presentations at the American Academy of Neurology Meeting
26. April 2012 11:01 ET
|
Transition Therapeutics Inc.
TORONTO, April 26, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced that three ELND-005 poster presentations were presented...
Transition Therapeutics to Present at the Cowen & Company 32nd Annual Health Care Conference
01. März 2012 10:55 ET
|
Transition Therapeutics Inc.
TORONTO, March 1, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH), (Nasdaq:TTHI) announced today that Dr. Tony Cruz, Chairman and Chief Executive...
Transition Therapeutics Announces Second Quarter Fiscal 2012 Financial Results
09. Februar 2012 16:01 ET
|
Transition Therapeutics Inc.
TORONTO, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2012 Financial Results on Thursday, February 9th, at 4:30 P.M. EST
07. Februar 2012 11:00 ET
|
Transition Therapeutics Inc.
TORONTO, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Thursday, February 9, 2012 at 4:30 P.M....
Transition Therapeutics Announces Initiation of a Phase 1 Clinical Study of Diabetes Drug Candidate TT-401
12. Dezember 2011 06:31 ET
|
Transition Therapeutics Inc.
TORONTO, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) announced today the first patient has been dosed in a Phase 1 clinical...
Transition Therapeutics Appoints New Chief Financial Officer
12. Dezember 2011 06:01 ET
|
Transition Therapeutics Inc.
TORONTO, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition") (TSX:TTH) today announces the appointment of Ms. Nicole Rusaw-George, C.A., as Chief Financial Officer of...